Prevention of neonatal hepatitis B virus transmission

Journal of Clinical Gastroenterology

Volumn 48, Issue 9, 2014, Pages 765-772

  Bleich, Lauren M ^a   Swenson, Eugene S ^a,b  

^a BRIDGEPORT HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis B; Immunoprophylaxis; Neonatal transmission

Indexed keywords

ADEFOVIR; ENTECAVIR; HEMOGLOBIN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; LAMIVUDINE; TELBIVUDINE; TENOFOVIR; VIRUS DNA; ANTIVIRUS AGENT;

ADULT; CASE REPORT; DELIVERY; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOPROPHYLAXIS; INFANT; INFECTION PREVENTION; INFECTION RISK; NEWBORN; NEWBORN HEPATITIS; NONHUMAN; PERINATAL PERIOD; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK FACTOR; VACCINATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; BLOOD; DRUG ADMINISTRATION; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PREVENTION AND CONTROL; TRANSMISSION;

ANTIVIRAL AGENTS; DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS;

EID: 84926004541     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000115     Document Type: Review

References (64)

1. World Health Organization (WHO). Hepatitis B vaccine. WHO Wkly Epidemiol Rec. 2009;84:405-420
2. Keeffe EB, DIeterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315-1341
3. Merion RM, Sharma P, Mathur AK, et al. Evidence-based development of liver allocation: a review. Transpl Int. 2011; 24:965-972
4. Centers for Disease Control and Prevention (CDC). Assessing completeness of perinatal hepatitis B virus infection reporting through comparison of immunization program and surveillance data: United States. MMWR Morb Mortal Wkly Rep. 2011;60:410-413
5. Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int. 2013;33(supp 1):188-194
6. Beasley RP, Trepo C, Stevens CE, et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105:94-98
7. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003;39(suppl 1):S64-S69
8. Sung Jl, Chen DS, Lai MY, et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chin J Gastroenterol. 1984;1:1-9
9. Centers for Disease Control and Prevention (CDC). Viral hepatitis surveillance-United States 2010. June 5, 2012. Available at: http://www.cdc.gov/hepatitis/statistics/2010sur veillance/Commentary.htm. Accessed May 29, 2013
10. Koumans EH, Rosen J, van Dyke MK, et al. Prevention of mother-to-child transmission of infections during pregnancy: implementation of recommended interventions, United States, 2003-2004. Am J Obstet Gynecol. 2012;206:158.e1-158.e11
11. Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis. 1978;138:668-671
12. Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of Hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10:452-459
13. Wang JS, Chen Z, Zhu QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol. 2005;11:3582-3585
14. Wang JS, Zhang J, Yang H, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol. 2003;71:360-365
15. Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepatol. 2012; 19:e18-e25
16. Chang MH, Hsu HY, Huang LM, et al. The role of transplacental hepatits B core antibody in the mother-toinfant transmission of hepatitis B virus. J Hepatol. 1996;24: 674-679
17. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003; 38:1075-1086
18. Burk RD, Hwang LY, Ho GY, et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis. 1994;170:1418-1423
19. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Austrialian experience. Med J Aust. 2009;190:489-492
20. del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine. 1997;15:1624-1630
21. del Canho R, Grosheide PM, Schalm SW, et al. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol. 1994;20:483-486
22. Liu SL, Dong Y, Zhang L, et al. Influence of HBV gene heterogeneity on the failure of immunization with HBV vaccines in eastern China. Arch Virol. 2009;154:437-443
23. Walz A, Wirth S, Hucke J, et al. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. J Infect Dis. 2009;200:1227-1231
24. Wang S, Peng G, Li M, et al. Identification of hepatitis B virus vertical transmission from father to fetus by directing sequencing. Southeast Asian J Trop Med Public Health. 2003; 34:106-113
25. Tacke F, Amini-Bavil-Olyaee S, Heim A, et al. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol. 2007;38:353-357
26. Xu YY, Yu JY, Zhong YV, et al. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci. 2008;4:111-115
27. Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl). 2005;118:1604-1609
28. Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy. Clin Res Hepatol Gastroenterol. 2011;35: 618-622
29. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and core blood. Am J Obstet Gynecol. 2001;184: 1514-1520
30. Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol. 1980;87:958-965
31. Beasley RP, Steven CE, Shiao IS, et al. Evidence against breastfeeding as a mechanism for vertical transmission of hepatitis B. Lancet. 1975;2:740-741
32. Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002;99:1049-1052
33. Petrova M, Kamburov V. Breast feeding and chronic HBV infection: clinical and social implications. World J Gastroenterol. 2010;16:5042-5046
34. World Health Organization (WHO). Hepatitis-b-and-breastfeeding. November 1996. Available at: http://www.who.int/child-adolescent-health/documents/pdfs/hepatitis-b-and-breast feeding.pdf. Accessed October 28, 2013
35. Jonas MM, Schiff ER, O'Sullivan MJ, et al. Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med. 1981;107:335-337
36. Reddy PA, Gupta I, Ganguly NK. Hepatitis-B vaccination in pregnancy: safety and immunogenic response in mothers and antibody transfer to neonates. Asia Oceania J Obstet Gynaecol. 1994;20:361-365
37. Ayoola EA, Johnson AO. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants. Int J Gynaecol Obstet. 1987;25:297-301
38. Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol. 1991;8:227-232
39. Grosheide PM, Schalm SW, van Os HC, et al. Immune response to hepatitis B vaccine in pregnant women receiving post-exposure prophylaxis. Eur J Obstet Gynecol Reprod Biol. 1993;50:53-58
40. Tran T. Hepatitis B and pregnancy. Curr Hepatol Rep. 2009; 8:154-156
41. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: doubleblind randomized placebo-controlled study. Lancet. 1984;1: 921-926
42. Tran TT, Keeffe EB. Management of the pregnant hepatitis B patient. Curr Hepatol Rep. 2008;2:43-48
43. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987;257:2597-2603
44. Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccinations. Hepatology. 2013;57:37-45
45. Zhu Q, Yu G, Yu H, et al. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl). 2003;116:685-687
46. Yuan J, Lin J, Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepatology. 2006; 13:597-604
47. Lee C, Gong Y, Brok J, et al. Hepatitis B immunization for newborn infants of hepatitis B surface antigen positive mothers. Cochrane Database Syst Review. 2006;CD004790
48. Yang J, Zeng XM, Men YL, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus: a systematic review. J Virol. 2008;5:100
49. Wang J, Zhu Q, Zhang X. Effect delivery mode on maternalinfant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J (Engl). 2002;115:1510-1512
50. Zou H, Chen Y, Duan Z, et al. A retrospective study for clinical outcome of caesarean section on perinatal transmission of hepatitis B virus in infants born to HBeAg positive mothers within chronic hepatitis B. Hepatology. 2010;52:235A
51. Pan CQ, Zou HB, Chen Y, et al. Cesarean section reduces perinatal transmission of HBV infection from surface antigenpositive women to their infants. Clin Gastroenterol Hepatol. 2013;11:1349-1355
52. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;110: 941-955
53. The Antiretroviral Pregnancy Registry Interim Report for 1 January 1989 through 31 July 2012. June 2013. Available at http://www.apregistry.com/forms/interim-report.pdf. Accessed June 3, 2013
54. Munderil P, Helen Wilkes H, Tumukunde D, et al. Pregnancy rates and outcomes among women on triple-drug antiretroviral therapy in the DART trial [Poster WEPEB2611]. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 19-22, 2009, Cape Town, South Africa: 2000
55. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicenter, randomized, double-blind, placebo-controlled study. J Viral Hepatol. 2009;16:94-103
56. Han L, Zhang HW, Xie JX, et al. A meta-analysis of lamivudine for interruption of mother to child transmission of hepatitis B virus. World J Gastroenterol. 2011;17:4321-4333
57. Shi Z, Yang Y, Ma L, et al. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116: 147-159
58. Njei B, Ditah IC, Kumar S, et al. Preventing hepatitis B materno-fetal transmission: a comparative meta-analysis of lamivudine vs HBIG. DDW poster presentation. San Diego CA; 2012
59. Han GR, Cao MK, Zhao W, et al. A prospective open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus to the infant. J Hepatol. 2011;55:1215-1221
60. Pan CQ, Han GR, Jiang HX, et al. Telbivudine prevents vertical transmission from HBeAg positive women with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10:520-526
61. Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antiviral Ther (Lond). 2011;16:621-628
62. Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant. Curr Hepatitis Rep. 2012;11:82-89
63. Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment of chronic hepatitis B in the United States. N Engl J Med. 1999;341:256-1263
64. ter Borg MJ, Leemans WF, de Man RA, et al. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepatol. 2008;15:37-41.